Thema: US69366J2006
PTCT, US69366J2006
ethereum-6851392_1920.jpg - Foto: THN
PTC Therapeutics stock: Q3 growth lifts 2026 outlook
PTC Therapeutics stock gains a fresh earnings catalyst as Sephience drives product revenue growth. Management also raised its 2026 outlook.
ad-hoc-news.de, heute 00:13 Uhr
PTCT, US69366J2006
PTC Therapeutics schedules October 29 results as stock trades ...
PTC Therapeutics reports third-quarter results on October 29, 2026. PTC Therapeutics stock costs EUR 55.60 on October 20, 2026.
ad-hoc-news.de, 20.10.26 18:54 Uhr
PTCT, US69366J2006
Truist sets USD 62.00 target for PTC Therapeutics stock
Second-quarter revenue reached USD 360.52 million on July 30, 2026. PTC Therapeutics stock last traded at USD 59.24 on October 16, 2026, down 2.87 percent on Nasdaq.
ad-hoc-news.de, 17.10.26 19:07 Uhr
PTCT, US69366J2006
UBS lifts PTC Therapeutics stock target to USD 90.00
Q2 revenue reached USD 360.52 million, up 101.50 percent year over year. PTC Therapeutics stock costs EUR 54.37 on October 15, 2026.
ad-hoc-news.de, 15.10.26 22:34 Uhr
PTCT, US69366J2006
PTC Therapeutics insider sold 1,638 shares while PTC Therapeutics ...
Q2 revenue reached USD 360.52 million, up 101.50 percent year over year. PTC Therapeutics stock costs EUR 55.74 on October 8, 2026 after EUR 56.51.
ad-hoc-news.de, 08.10.26 22:09 Uhr
PTCT, US69366J2006
Cantor raises target for PTC Therapeutics stock to USD 137.00 ...
Revenue rose 101.50 percent to USD 360.52 million in the second quarter. PTC Therapeutics stock had an EUR 56.57 prior close on October 5, 2026.
ad-hoc-news.de, 07.10.26 03:50 Uhr
PTCT, US69366J2006
PTC Therapeutics stock rises as third quarter data strengthen ...
PTC Therapeutics stock traded at USD 140.00 on September 23, 2026, after a 3.5 percent rise. Third-quarter net new ARR reached USD 60 million.
ad-hoc-news.de, 23.09.26 15:38 Uhr
